Tuesday, January 19, 2016 11:17:02 AM
Welcome aboard mr.big,
Long term we will be bucks, short term traders want the news
yesterday, we also had no share holder meeting in 2015.
you revenues from generics will be up 100%+ this year but again
company has not provided revenue guidance, launch news etc. so
fuds have a lot of silence to work their magic with.
the waiving of fee by fda saved us 2 mill. but extended the wait
time is perception by flippers , shorters verdict is still out
as opiate news out every two days may sway fda to act fast.
NO MAIN STREAM PRINT AIDS SHORTIES AS WELL
biggest news is IF FDA GREEN LIGHTS ELI 200 AND MOST REALIZE
WIITH A PHASE 3 PASS, IT ALREADY HAS THEN FDA IS REALLY SAYING
WE APPROVE OF 2 BEAD/TECH AND ENTIRE ELI LINE HAS BEEN APPROVED.
guy,
sincerely, if any dots get connected by the "Street" we will
instantly be above a buck, we should already be there
based on what happens to most bios with a phase 3 pass
I WOULD NOT TRY TO PLAY GAMES AT THIS POINT WITH ELTP, AS NEWS
MERGER, BUY OUT COULD COME ANY TIME NOW, AND MAY VERY WELL COME
IN AN AFTER HOURS SESSION, RETAILERS ARE AT SUCH A DIS ADVANTAGE
DURING THESE MOMENTS.
ELTP WILL PROVIDE A PERMANENT WEALTH TRANSFER, NO ONE IS GOING
TO STOP THIS NO ONE.
SNUP
Long term we will be bucks, short term traders want the news
yesterday, we also had no share holder meeting in 2015.
you revenues from generics will be up 100%+ this year but again
company has not provided revenue guidance, launch news etc. so
fuds have a lot of silence to work their magic with.
the waiving of fee by fda saved us 2 mill. but extended the wait
time is perception by flippers , shorters verdict is still out
as opiate news out every two days may sway fda to act fast.
NO MAIN STREAM PRINT AIDS SHORTIES AS WELL
biggest news is IF FDA GREEN LIGHTS ELI 200 AND MOST REALIZE
WIITH A PHASE 3 PASS, IT ALREADY HAS THEN FDA IS REALLY SAYING
WE APPROVE OF 2 BEAD/TECH AND ENTIRE ELI LINE HAS BEEN APPROVED.
guy,
sincerely, if any dots get connected by the "Street" we will
instantly be above a buck, we should already be there
based on what happens to most bios with a phase 3 pass
I WOULD NOT TRY TO PLAY GAMES AT THIS POINT WITH ELTP, AS NEWS
MERGER, BUY OUT COULD COME ANY TIME NOW, AND MAY VERY WELL COME
IN AN AFTER HOURS SESSION, RETAILERS ARE AT SUCH A DIS ADVANTAGE
DURING THESE MOMENTS.
ELTP WILL PROVIDE A PERMANENT WEALTH TRANSFER, NO ONE IS GOING
TO STOP THIS NO ONE.
SNUP
Recent ELTP News
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 12:05:23 PM
- Elite Pharmaceuticals Announces Commercial Launch of Methadone Hydrochloride Tablets • Newsfile • 04/02/2026 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/17/2026 10:10:32 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2026 (three months ended December 31, 2025) and Provides Conference Call Information • Newsfile • 02/17/2026 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/17/2026 09:06:15 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/11/2026 09:35:26 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Third Quarter 2026 Financial Results on February 18, 2026 • Newsfile • 02/11/2026 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2026 09:35:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/14/2025 10:10:23 PM
- Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2026 Ended September 30, 2025 and Provides Conference Call Information • Newsfile • 11/14/2025 09:19:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:11:38 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2025 10:19:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/12/2025 12:15:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/10/2025 12:15:46 PM
- Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2026 Financial Results on November 17, 2025 • Newsfile • 11/10/2025 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/26/2025 09:17:39 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 08/22/2025 01:39:01 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/14/2025 08:37:09 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2025 08:35:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/25/2025 10:05:07 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/10/2025 08:17:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/08/2025 08:15:11 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/08/2025 02:58:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/30/2025 08:27:51 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 06/30/2025 08:05:59 PM
